News and Media
;
Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer
OICR’s PanCuRx program is unlocking the mysteries behind Canada’s fourth leading cause of cancer death and translating knowledge into better treatment options. Tough to detect, quick to spread and stubbornly resistant to treatment, pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer. Most people won’t have symptoms in the early stages, giving […]
Read the story
Sep 27, 2022
The Next Generation: Mahmoud Noureldin
Sep 14, 2022
New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals
Aug 29, 2022
Drug discovery collaboration takes aim at novel targets
Aug 24, 2022
Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging
Aug 15, 2022
Trusting the gut in cancer research: Q&A with Dr. Saman Maleki
Aug 11, 2022
Funding from Ontario Institute for Cancer Research to help move research from experiment to impact
Recent Videos
Media Contact
Resources
OICR Brand Guidelines
Jul 28, 2021
Download the OICR brand guidelines.
News Releases
Aug 11, 2022
Funding from Ontario Institute for Cancer Research to help move research from experiment to impact
Jun 16, 2022
OICR announces funding for three new window-of-opportunity clinical trials
Dec 02, 2021
Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients
@OICR_News on Twitter
Congratulations to Dr. Samuel Weiss on his induction into the Canadian Medical Hall of Fame! Dr. Weiss is co-leader of the OICR-supported @su2c_canada Cancer Stem Cell Dream Team. 👏
#2023CMHFInductee Samuel Weiss, PhD @RockyMtnBrain | Trailblazer in establishing neurogenesis research as a pathway to treatments for wasting diseases such as Parkinson’s, Alzheimer’s, stroke, ALS, and multiple sclerosis. https://bit.ly/3LU1LeH @mcgillmed @UCalgaryMed @CNRS
The Toronto Bioinformatics User Group is kicking off its 2022-23 season tomorrow! Visit https://torbug.org/ for details. #bioinformatics #informatics
Mahmoud Noureldin, a PhD student in the University of Toronto’s Pharmacology and Toxicology Department, shares how he is working within OICR's Drug Discovery Program to investigate a new therapeutic target for #lungcancer.
Today we join all those marking #WorldCancerResearchDay in celebrating progress made in cancer prevention and early detection. OICR is committed to advancing this vital area of research to make sure every patient has the best opportunity to beat cancer. http://ow.ly/rUBC50KRMLX
Read the top stories in #cancerresearch news this week: http://ow.ly/2ilN50KRRNy
#braincancer #immunotherapy #clinicaltrials #prostatecancer #genomics #breastcancer #earlydetection
@thesgconline in collaboration with @OICR_news is leading the way towards accelerated drug discovery solutions through a global open science model!
#openscience #chemicalprobes @EUbOPEN https://twitter.com/OICR_news/status/1572292146358784001
An #openscience project led by OICR’s Drug Discovery Program and the @thesgconline is targeting a previously overlooked family of proteins and found that inhibiting them with small molecules could play an important role in slowing cancer. http://ow.ly/UNJR50KOh7v
@CherylArrowsmi1
It's #ScienceLiteracyWeek! Check out this list for fun in-person and online events that take you inside some of the most interesting Canadian science. There is something for everyone - from pre-schoolers to adults.
https://www.scienceliteracy.ca/events/
Great work by the @OICRRisingStars team on their latest newsletter. In it you can read about some fascinating trainee-led research, how trainees can engage patient partners in research and more!
@themichaelhe @TheNotoriousAOG @BeccaBurchett @jillbrownn @NTaimoory
📰📢Our latest Newsletter "The Rising Stars Quarterly" Summer/Fall 2022 Edition is just out!
🌟Check out the stories behind the papers by our outstanding cancer research trainees and learn how patient partners are involved in cancer research!
More info👇
https://mailchi.mp/69aceb1dbf13/rising-stars-quarterly-summerfall2022?e=1fba545cc6
An #openscience project led by OICR’s Drug Discovery Program and the @thesgconline is targeting a previously overlooked family of proteins and found that inhibiting them with small molecules could play an important role in slowing cancer.
@CherylArrowsmi1
Drug discovery collaboration takes aim at novel targets - Ontario Institute for Cancer Research
An open science project led by OICR‘s Drug Discovery Program and the Structural Genomics Consortium is targeting...
ow.ly
OICR's President and Scientific Director @RadvanyiLaszlo spoke to Health Insight about the potential of immunotherapies in early cancers, OICR's Window-of-Opportunity Network, and how it's #clinicaltrials are part of a new era in #immunotherapy.
OICR Fuels Innovative Research on Activating Our Immune System against Cancer - Health Insight
Ontario Institute for Cancer Research (OICR) works with partners to accelerate the development of cancer research disc...
ow.ly
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.